Eu­roAPI halts pro­duc­tion at Ital­ian site as qual­i­ty con­trol is­sues due to ‘po­ten­tial’ mis­con­duct come to light

Eu­roAPI is paus­ing all pro­duc­tion at its site in Brin­disi, Italy, caus­ing Sanofi’s API spin­off to de­lay its 2024 guid­ance un­til the sec­ond quar­ter.

“Fol­low­ing an in­ter­nal au­dit, qual­i­ty con­trol de­fi­cien­cies due to po­ten­tial lo­cal mis­con­duct have been iden­ti­fied and are be­ing fur­ther in­ves­ti­gat­ed,” the com­pa­ny said in a Thurs­day re­lease. “Pro­duc­tion will re­main sus­pend­ed un­til fur­ther no­tice. The rel­e­vant health au­thor­i­ties have been in­formed. The com­pa­ny has ini­ti­at­ed a foren­sic au­dit and will in­form its cus­tomers.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER